Steven Cohen’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRA
EC
RG
SCA
Steven Cohen's ATRA Position: Q2 2026 in Review
Steven Cohen increased its Atara Biotherapeutics (ATRA) stake by 254% in Q2 2026, buying an estimated $3.94M and bringing the position to 687,718 shares worth $7.9M. The position accounts for 0.01% of the portfolio, ranked #1434.
Steven Cohen first reported a position in ATRA in Q1 2015 and has held it in 17 quarters since. The position peaked at $72.7M in Q4 2021. 36 funds tracked by Wall St. Rank hold ATRA as of Q2 2026.
- Steven Cohen held 687,718 shares of Atara Biotherapeutics worth $7.9M as of Q2 2026.
- Steven Cohen bought 493,454 Atara Biotherapeutics shares in Q2 2026, an estimated $3.94M.
- Atara Biotherapeutics made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1434 holding.
- Steven Cohen first reported a position in Atara Biotherapeutics in Q1 2015 and has held it in 17 quarters since.
- Steven Cohen's Atara Biotherapeutics position peaked at $72.7M in Q4 2021.
- 36 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.